Success Metrics

Clinical Success Rate
93.8%

Based on 15 completed trials

Completion Rate
94%(15/16)
Active Trials
1(6%)
Results Posted
20%(3 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_1
17
100%

Phase Distribution

17

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
17(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

93.8%

15 of 16 finished

Non-Completion Rate

6.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

17

all time

Status Distribution
Active(1)
Completed(15)
Terminated(1)

Detailed Status

Completed15
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
1
Success Rate
93.8%
Most Advanced
Phase 1

Trials by Phase

Phase 117 (100.0%)

Trials by Status

completed1588%
terminated16%
recruiting16%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT04589611Phase 1

Translating Metabolic Responses to Mechanical Insult Into Early Interventions to Prevent PTOA

Terminated
NCT03945318Phase 1

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Completed
NCT06391827Phase 1

A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants

Completed
NCT06705998Phase 1

To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects

Recruiting
NCT04926701Phase 1

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD001 in Healthy Subjects

Completed
NCT04488705Phase 1

A First in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Inhaled ETD002 in Healthy Subjects

Completed
NCT04526496Phase 1

Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers

Completed
NCT04138849Phase 1

Evaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male

Completed
NCT03740555Phase 1

A Study of HNC042 in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics.

Completed
NCT02509117Phase 1

First-In-Human Study Of Single And Multiple Ascending Doses Of PF-06751979

Completed
NCT02793232Phase 1

Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.

Completed
NCT03128606Phase 1

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects.

Completed
NCT03410979Phase 1

A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2737 in Healthy Subjects

Completed
NCT02662452Phase 1

First-in-Human Single and Multiple Dose of GLPG2222

Completed
NCT02612246Phase 1

First-in-Human Single and Multiple Dose of GLPG1972

Completed
NCT02325037Phase 1

First-in-Human Single and Multiple Dose of GLPG1837

Completed
NCT01840501Phase 1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-42721458 in Healthy Male Participants

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17